Thanks for your informative post. Yes that embargo that has kept results under wraps, which is nothing unusual in Biotechs.
I think you are right that trial results are implied to be positive, but the company cannot disclose until that embargo is lifted.
I guess we already knew this with the Janssen collaboration moving into the second phase (or it would have been canned), that was a massive clue from March, so assumed knowledge for us.
I think in particular this statement from the presentation, page 12:
”Upcoming FDA Regulatory approval process should be accelerated by using the Janssen/PromarkerD data.”
I got really excited yesterday when I saw the pause in trading & where the SP was at haha! Alas an ASX query, & I hope there is no bother with the ASX, PIQ is not a dodgy stock.
Thanks for your comments re DXB also. Our turn here next.
Not long to wait for results now everyone!
GLTAH
PIQ Price at posting:
45.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)